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ABSTRACT 
 
A significant decline of gonorrhea incidence has been observed during the years 1990-99. 
However, a slight increase in the number of cases has been reported in 2000. In addition, an 
increase in resistant strains has been found in Thailand. In this study, 207 isolates of N. 
gonorrhoeae from patients attending Bangrak hospital (National Centre of Sexually 
Transmitted Infections), 67 isolates obtained during January-March 2000, 74 isolates obtained 
during January-March 2002, and 66 isolates obtained during October-December 2002, were 
tested. All isolates were susceptible to ceftriaxone while 71.5% and 74.4% were resistant to 
penicillin and quinolone, respectively. The high level of ciprofloxacin resistance (MIC ≥4 
mg/L) also increased from 13.4% during January-March 2000 to 25.8% during October-
December 2002. Multiple resistance determinants commonly coexisted in a single isolate so 
that the level of resistance was increased. The incidence of double resistance determinants, 
penicillin and quinolone resistance, were significantly increased from 34.3% among isolates 
during January to March 2000 up to 77.3% among isolates during October to December 2002 
(P < 0.001). In addition, an isolate obtained in 2002 resisted to spectinomycin with a high 
MIC (>1.024 g/L). Several plasmid patterns have been identified and various patterns of the 
plasmid can be artificially transferred and maintained their expression in Escherichia coli 
transformants. Such evidences infer the high mobility of resistant genome among 
microorganisms in the region. Moreover, the significant increase in penicillin and quinolone 
resistance herein, indicates the selective pressure and the diversity of genomic distribution 
among N. gonorrhoeae in Thailand. Primers JDA (5’-TAC TCA ATC GGT AAT TGG CTT 
C-3’) and JDB (5’-CCA TAT CAC CGT CGG TAC TG-3’) have been designed from 
sequences of the Asia, the Africa, and the Toronto β-lactamase plasmids. By using the JDA 
and the JDB as PCR primers, our data reveal the highest prevalence and a significantly 
increasing trend of the epidemic Africa type of genomic β−lactamase. 
Keywords: Neissseria gonorrhoeae, antimicrobial susceptibility, quinolone resistance, 
penicillin resistance 
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INTRODUCTION 
 
Gonorrhea remains one of the most 
common sexually transmitted infections 
(STIs) in developing countries, especially in 
South and Southeast Asia (Gerbase et al., 
1998a; Gerbase et al., 1998b). Approxi-
mately 62 million cases of gonorrhea among 
the 340 million cases of curable sexually 
transmitted infections (gonorrhea, chlamydia, 
syphilis, and trichomoniasis) have occurred 
worldwide in 1999. The global health 
problem is concerned with the development 
of antimicrobial resistance of N. gonorrhoeae 
due to the wide dissemination of resistant 
clones and emerging of novel resistance 
(Knapp et al., 1997a). Southeast Asia is most 
likely an origin of drug resistance (Joesoef et 
al., 1994; Putnam et al., 1992). Penicillinase-
producing strains have been firstly isolated in 
1976 in Southeast Asia, and resistance to 
spectinomycin and tetracycline of gonococci 
has emerged in the 1980s. Fluoroquinolone-
resistant gonococci have been found in 
several Asian countries during the early 
1990s reaching the high level in Hong Kong, 
the Philippines, Japan, and Singapore (Knapp 
et al., 1997a; Putnam et al., 1992; Tanaka et 
al., 2000). 
The third-generation cephalosporins, 
fluoroquinolones, and spectinomycin are 
included for the treatment recommendation 
of gonorrhea by the World Health 
Organization (WHO). They have been 
proven to have excellent efficacy while 
emergence of resistance remains a serious 
matter for combating the infection. The 
levels of gonococcal resistance to penicillins, 
tetracyclines, and fluoroquinolones have 
been frequently reported. The treatment has 
thus become more and more complicated 
particularly due to a multiple resistance. In 
China, the multiple resistances of gonococci 
to spectinomycin and ciprofloxacin have 
been reported (Li et al., 2000). This study is 
aimed to validate the antimicrobial 
susceptibilities of N. gonorrhoeae isolated in 
Thailand. Production of β-lactamase and 
genomic of the resistance are also unveiled 
among the gonococci. 
MATERIALS AND METHODS 
 
N. gonorrhoeae strains 
A total of 207 clinical isolates of N. 
gonorrhoeae, 67 isolates obtained from 
January to March 2000, 74 isolates obtained 
from January to March 2002, and 66 isolates 
obtained from October to December 2002, 
were tested. All isolates of N. gonorrhoeae 
were collected from patients with gonorrhea 
attending the national center for sexually 
transmitted infection clinic in Bangrak 
hospital. N. gonorrhoeae was identified 
based on the appearance of Gram-negative 
diplococci, positive oxidase reaction, and 
sugar utilization patterns. The isolates were 
suspended in 10% skimmed milk with 15% 
glycerol and stored at -80oC until further 
experiment. Cultivation was performed on 
chocolate agar (Gonococcal base medium 
supplemented with 1% bovine hemoglobin 
and 1% isovitalex) in a moist candle jar at 
33-35oC.  
 
Beta-lactamase detection 
Production of β-lactamase was detected 
using the chromogenic cephalosporin 
(nitrocefin, Oxoid) as substrate. Penicillinase 
producing Neisseria gonorrhoeae (PPNG) 
and non PPNG were used as controls.  
 
Antimicrobial susceptibility testing 
Minimum inhibitory concentrations 
(MICs) were determined by the E-test on a 
chocolate agar plate. Briefly, N. gonorrhoeae 
isolates were suspended in tryptic soy broth 
(TSB) to a turbidity equivalent to a 0.5 
McFarland standard No.1. Chocolate agar 
plates were spread over the entire surface 
with a swab to deliver the bacterial 
suspension. The E-test strips containing an 
exponential antibiotic gradient on one side 
and an MIC reading scale marked on the 
other was firmly placed on the culture 
surface. The culture plate was then incubated 
in a moist candle jar for 24 h at 35°C. MICs 
were determined by recording of value at the 
point of intersection between the edge of the 
zone of growth inhibition and the strip. The 
antimicrobial agents tested were penicillin G, 
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spectinomycin, ceftriaxone, norfloxacin, 
ofloxacin, and ciprofloxacin. Interpretive 
criteria for susceptibility testing of all 
antimicrobial agents were used according to 
the National Committee for Clinical 
Laboratory Standards (NCCLS, 2004) except 
norfloxacin was followed the Centers for 
Disease Control and Prevention (CDC) 
(Knapp et al., 1997a). The MIC for 
interpretive results to penicillin, 
spectinomycin, norfloxacin, ofloxacin, and 
ciprofloxacin were ≤ 0.06 mg/L, ≤ 32 mg/L, 
≤ 0.25 mg/L, ≤ 0.25 mg/L, and ≤ 0.06 mg/L 
for susceptible isolates while ≥ 2 mg/L, ≥ 
128 mg/L, ≥ 1 mg/L, ≥ 2 mg/L, and ≥ 1 mg/L 
were for resistant isolates, respectively. 
 
Isolation of plasmid DNA and transfor-
mation 
Plasmid extraction 
Plasmid DNA of N. gonorrhoeae was 
prepared by alkaline lysis method (Sambrook 
et al., 1990). Suspended DNA was treated 
with RNase A (final concentration 20 mg/L) 
before analyzed on 0.7% agarose gel 
electrophoresis.  
Transformation 
Escherichia coli strain TG1 was 
cultivated in LB medium and transformed 
with plasmid by using the conventional 
calcium chloride method (Sambrook et al., 
1990). Transformants were selected on 
ampicillin plate and transferring plasmids 
were analyzed on 0.7% agarose gel 
electrophoresis. The restriction enzymes, 
HindIII, PstI, EcoRI, BamHI, were used as 
described by the manufacturer’s instructions. 
 
Susceptibility testing 
Antimicrobial susceptibility was tested 
using a disc diffusion method for the 
transformants. The obtained ampicillin 
resistant transformants were tested against 
amoxicillin-clavulanate (20 μg/10 μg), 
chloramphenicol (30 μg), tetracycline (30 
μg), sulfamethoxazole-trimethoprim (23.75 
μg/1.25 μg), gentamicin (10 μg), norfloxacin 
(10 μg), and ciprofloxacin (5 μg). 
 
PCR amplification of the β-lactamase 
producing plasmids 
Primers JDA (5’-TAC TCA ATC GGT 
AAT TGG CTT C-3’) and JDB (5’-CCA 
TAT CAC CGT CGG TAC TG-3’) have 
been designed from sequences of the Asia, 
the Africa, and the Toronto β-lactamase 
plasmids by Dillon et al (1999). Whole cells 
were suspended in distilled water at a 0.5 
McFarland standard No. 1 and used as a 
template. PCR amplification was performed 
in 25 µl of a reaction mixture which 
contained 2.5 µl of 10x PCR buffer 
containing 15 mM MgCl2, 2.5 µl of each 
primers (10 pmol/µl), 2.5 µl of each of the 
four deoxyribonucleotide triphosphates (2 
mM), 0.3 µl of Taq DNA polymerase (1 
U/µl) (Fermentas), and 6 µl of template. 
After an initial incubation at 94°C for 10 
min, 30 cycles were conducted with 
denaturing at 94°C for 30 s, annealing at 
60°C for 30 s and extension at 72°C for 5 
min, with a final extension at 72°C for 10 
min. A cell suspension of E. coli TG1 
containing no gonococcal plasmids and non-
penicillinase producing Neisseria 
gonorrhoeae were used as negative controls. 
 
Statistical analysis 
Data were analyzed by chi-square test 
(Eveillard et al., 2005). Statistical signi-
ficance for all P-values was set at 0.05. 
 
RESULTS 
 
Trends of multiple drug resistance 
Susceptibility to various antimicrobial 
agents of all together the 67 isolates obtained 
during January to March 2000, 74 isolates 
obtained during January to March 2002, and 
66 isolates obtained during October to 
December 2002 were summarized in Table 1. 
Among the 207 isolates, only 22 (10.6%) 
isolates were susceptible to all antimicrobial 
agents including penicillin, ceftriaxone, 
norfloxacin, ofloxacin, ciprofloxacin, and 
spectinomycin. On the other hand, 148 
(71.5%) isolates were resistant to penicillin 
(MIC, 2.0 μg/ml) and all were positive for β-
 132
Table 1 Antibiotic susceptibility of 207 N. gonorrhoeae isolates from Bangkok during the 
period of January to March 2000, January to March 2002 and October to December 2002. 
Susceptibility (mg/L) 
January-March 2000  
(n=67) 
January-March 2002 
(n=74) 
October-December 2002 
(n=66) 
 
Antibiotics 
MIC range MIC50 MIC90 MIC range MIC50 MIC90 MIC range MIC50 MIC90
Penicillin   0.032->256  2 64 0.064->256 6 96   0.064->256 12 128 
Norfloxacin   0.003-96  1 12 0.016-16 2 16    0.016-32   4  12 
Ofloxacin   0.006->32 0.380   8 0.002-16 0.750 12    0.006-16   3  12 
Ciprofloxacin   0.002->32 0.125   4 0.002-8 0.250  4    0.003-16   1    6 
Spectinomycin   4-16 12 16 4->1,024 6  8     4-16   8  12 
Ceftriaxone <0.002-0.047 0.004 0.008 0.002-0.023 0.004 0.008<0.002-0.032 0.004 0.008
 
lactamase production. The MIC50 ratios of 
penicillin, calculated by dividing the MIC50 
for the isolates from 2002 by the MIC50 for 
the isolates from 2000, showed a 3-fold 
difference for January-March 2002 and a 6-
fold difference for October-December 2002. 
For quinolone resistance, the MIC50 ratios 
also showed 2 to 8 fold differences. Figure 1 
showed isolation rates per period of N. 
gonorrhoeae strains that were resistant and 
less susceptible to penicillin, norfloxacin, 
ofloxacin, ciprofloxacin, and spectinomycin. 
The number of ciprofloxacin, ofloxacin and 
norfloxacin-resistant strains were increased 
from 28%, 28% and 64% during January-
March 2000 to 56%, 68% and 86% during 
October-December 2002, respectively. These 
differences were statistically significant (P < 
0.005). With the exception of 2 strains, all 
ciprofloxacin-resistant strains were also 
found to be ofloxacin-resistant (n = 83).      
In addition,  there  was  a positive correlation 
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Figure 1: Percentage of Neisseria gonorrhoeae isolates from Bangrak hospital, Bangkok, in 
each period that were resistant and less susceptible to penicillin, quinolones (norfloxacin, 
ofloxacin, ciprofloxacin), and spectinomycin.  
Percent Resistance in 2000 (Jan-Mar)        Less susceptible in 2000 (Jan-Mar) 
Percent Resistance in 2002 (Jan-Mar)        Less susceptible in 2002 (Jan-Mar) 
Percent Resistance in 2002 (Oct-Dec)        Less susceptible in 2002 (Oct-Dec) 
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between the susceptibility to ciprofloxacin 
and ofloxacin in all strains tested (r2= 0.93). 
The high level of ciprofloxacin resistance 
(MIC ≥ 4 mg/L) was also found increased 
from 13.4% during January-March 2000 up 
to 20.3% and 25.8% during January-March 
2002 and during October-December 2002, 
respectively. In addition, multiple resistance 
determinants coexisted in a single isolate 
were significantly found in 2002 (Table 2). 
The prevalence of double resistance 
determinants, penicillin and quinolone 
resistance, were significantly increased from 
34.3% among isolates during January-March 
2000 to 58.1% among isolates during 
January-March 2002 (P < 0.01) and 77.3% 
among isolates during October-December 
2002 (P < 0.001). Moreover, during January-
March 2002 one isolate was found resisting 
to spectinomycin with a very high MIC of > 
1.024 g/L. 
 
Ampicillin resistance and genomic type of 
β−lactamase 
Elevated trend of penicillin resistance 
was observed. The PPNG isolates increased 
significantly from 50.7% during January-
March 2000 to 75.7% during January-March 
2002  (P = 0.002) and 87.9% during October- 
December 2002 (P < 0.001). By using the 
JDA and the JDB primers, all 167 PPNG 
isolates except one were identified to carry 
β−lactamase plasmids by PCR. This was 
confirmed by HinfI restriction enzyme 
digestion. The amplified products of 4.9, 3.1 
and 2.6 kb were revealed. The band sizes of 
amplicon were corresponding to the Asia, the 
Africa and the Toronto/Rio-type plasmids,   
respectively (Figure 2). The Asia type 
plasmid was found in 24 (14.5%) isolates 
while 101 (60.8%) isolates contained the 
Africa type plasmid and 41 (24.7%) isolates 
contained the Toronto type plasmid. These 
epidemic plasmids were reported in each 
period with different percentages. The Africa 
type was increased significantly from 24.2% 
during January-March 2000 to 61.4% during 
January-March 2002 (P < 0.001) and 76.3% 
during October-December 2002 (P < 
0.0001). On the other hand, the Asia type and 
the Toronto type were markedly decreased 
from 27.3% and 48.5% during January-
March 2000 to 3.9% and 19.7% during 
October-December 2002 (Figure 3). 
Interestingly, the Africa type plasmid 
carrying isolates showed lower penicillin 
MIC comparing to the Asia and the Toronto 
type   plasmid   carrying   isolates  (Figure 4).  
Table 2 Distribution of antibiotic resistance and co-resistant among N. gonorrhoeae isolated 
from patients at various time periods. 
Drug resistances January-March 
2000 (n=67) 
January-March 
2002 (n=74) 
October-
December 
2002 (n=66) 
Susceptible 13 (19.4%) 7 (9.5%)        2 (3.0%) 
Penicillinase producing  
N. gonorrhoeae (PPNG) 
11 (16.4%) 13 (17.6%)      7 (10.6%) 
Quinolone resistances 20 (29.9%) 11 (14.9%)        6 (9.1%) 
    Norfloxacin resistance 20 (29.9) 11 (14.9)           6 (9.1) 
    Ofloxacin resistance 7 (10.4) 3 (4.1)           5 (7.6) 
    Ciprofloxacin resistance 7 (10.4) 3 (4.1)           5 (7.6) 
PPNG and Quinolone resistances 23 (34.3%) 42 (56.8%)    51 (77.3%) 
    PPNG and Norfloxacin resistance 23 (34.3) 42 (56.8)       51 (77.3) 
    PPNG and Ofloxacin resistance 12 (17.9) 28 (37.8)       40 (60.6) 
    PPNG and Ciprofloxacin resistance 12 (17.9) 26 (35.1)       32 (48.5) 
PPNG, Norfloxacin and 
Spectinomycin resistance 
0 (0.0%) 1 (1.4%)        0 (0.0%) 
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  1      2     3      4      5      6      7     M 
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Figure 2: Gel representative of PCR amplicons of β−lactamase producing genomic types 
from Neisseria gonorrhoeae isolates. Lane 1 represented product of the Toronto type, lane 2, 
3, and 5 represented product of the Africa type and 4, 6-7 represented product of the Asia 
type. Lane M is a lambda Hind III/EcoR I fragments. 
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Figure 3: Mobility of Penicillinase producing Neisseria gonorrhoeae (PPNG) distributed 
among types of β-lactamase from isolates obtained from patients of Bangrak hospital, 
Bangkok at different time frame. 
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Figure 4: Corresponding of genomic resistance types and MICs in penicillinase producing 
Neisseria gonorrhoeae (PPNG) isolates from patients of Bangrak hospital, Bangkok. 
 
Furthermore, the Asia, the Africa, and the 
Toronto type plasmids could be transferred 
and continuously expressed in E. coli. 
 
Transferable antibiotic resistance plasmids 
All 207 N. gonorrhoeae isolates carried 
plasmids that could be purified by alkaline 
lysis methods. The plasmids from individual 
organism were classified into patterns and all 
patterns remained their unique self-individual 
patterns after digestion with four restriction 
enzymes, PstI, EcoRI, HindIII, and BamHI. 
There was no significant difference in 
plasmid profiles between the strains in each 
antimicrobial susceptibility pattern. By 
randomly selection, we found that plasmid 
profiles of penicillin resistant isolates from 
each pattern could be transferred by artificial 
transformation and expressing ampicillin 
resistance in E. coli transformants. Although 
multiple resistance determinants were 
detected in N. gonorrhoeae, transformants 
did not show the co-resistance determinants 
with any kinds of antimicrobials (chloram-
phenicol, tetracycline, sulfamethoxazole-
trimethoprim, gentamicin, norfloxacin, or 
ciprofloxacin). In addition, production of 
β−lactamase in transformants was inhibited 
by clavulanic acid.  
Ampicillin resistance plasmids were 
successfully maintained in the E. coli host 
under ampicillin selective pressure. The 
plasmid profiles from ampicillin resistance E. 
coli transformants were classified into three 
patterns and the diversity of plasmids was 
identified (Figure 5). We found that these 
three types of plasmid could be Asia, Africa, 
and Toronto types after digestion with the 
restriction enzymes PstI, EcoRI, HindIII, and 
BamHI. Using primers JDA and JDB, we 
revealed the same plasmid types as in the 
original N. gonorrhoeae isolates (Figure 2). 
 
DICUSSION 
 
Herein, we report a high prevalence of 
resistant strains in Thailand. In 2002, the 
penicillin and ciprofloxacin resistance 
isolates has been found to be 81% and 47%, 
respectively. This result is agreed with the 
report of the WHO Western Pacific 
Gonococcal Antimicrobial Surveillance 
Programme (WHO, 2002). Generally, the 
prevalence  of  both  penicillin and quinolone 
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Figure 5: Gel representative of plasmid profiles of ampicillin resistance transformants. Lane 
1-2 represented pattern I, lane 3-4 represented pattern II, lane 5-7 represented pattern III, 
and lane M is a Lambda Hind III fragments. 
 
resistance are high in Southeast Asia and 
some of the Asian countries. This has been 
supported by the reports in Laos (100%), the 
Philippines (92%), Malaysia (60%), Brunei 
(60%), Singapore (55%), and Vietnam 
(30%). For quinolone resistance, a very high 
proportion of QRNG (Quinolone resistance 
Neisseria gonorrhoeae) was found in Korea 
(95%), Hong Kong (94%), China (93%), 
Japan (84%), Vietnam (79%), Laos (76%), 
Brunei (64%), the Philippines (60%), 
Singapore (51%), and Malaysia (50%). Most 
of the QRNG in these countries display high-
level drug resistance. These results are 
different from the isolates from Australia and 
New Zealand in which less than 20% of them 
are penicillin or quinolone resistance. We 
also find the elevated trend of antimicrobial 
resistance during 2000-2002. This is agreed 
with several recent reports on gonococci 
from many regions. Moodley and Strum 
(2005) have reported the increasing trend of 
ciprofloxacin resistance in South Africa 
during 2002-2005 while the QRNG has been 
found increasing in many global regions 
(Martin et al., 2005; Katz et al., 2003; Ray et 
al., 2005). Emergence and spread of QRNG 
may have been accelerated by heavy use of 
the quinolones. Although, penicillin and 
quinolones are no longer recommended for 
the treatment of gonorrhea in Southeast 
Asian countries, application of both drugs on 
the treatment of unrelated infections may 
continue to exert selective pressure on 
gonococcal strains.  
Unlike penicillin and quinolones, 
spectinomycin and ceftriaxone continue to be 
useful for the treatment of gonorrhea in many 
geographical areas including Thailand. There 
is no reported case of treatment failure with 
the third generation cephalosporin. However, 
we report a spectinomycin resistance isolate 
in 2002 with a very high MIC. 
Spectinomycin resistant isolates have 
sporadically been found in many regions. 
The resistance to spectinomycin usually 
occurs by chromosomal mutation resulting in 
high level resistance. In Southeast Asia, 
Clendennen et al (1992a) have reported since 
1989 that 8.5% of 117 isolates from the 
Philippines are resistant to spectinomycin. 
This finding is corresponded to the 
observation from Thailand in 1990 
(Clendennen et al., 1992b). Therefore, it is 
important to monitor the drug susceptibility 
testing as well as the clinical efficacy of this 
regimen since spectinomycin is commonly 
used in Thailand. 
Resistance to penicillin can be mediated 
both by chromosomal change to effect the 
penicillin binding proteins (PBPs) and by 
production of β−lactamase via episome. Both 
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chromosomally mediated resistance 
(CMRNG) and penicillinase-mediated 
resistance (PPNG) are widespread. The 
increase on prevalence of penicillin 
resistance from our findings reveals a steady 
increasing trend of the resistance in Thailand. 
Penicillin resistance isolates have been 
reported to be 64.9% in 1990 (Clendennen et 
al., 1992b), 77.2% during 1994-1995 (Knapp 
et al., 1997c), 50.7% in January-March 2000 
(this study), 75.7% in January-March 2002 
(this study) and 87.9% in October-December 
2002 (this study).  
Several kinds of ampicillin resistance 
plasmids have been found in N. gonorrhoeae 
such as the Asia (7426 bp), the Africa (5599 
bp), the Toronto (5154 bp), the Rio (5154 
bp), the Nymes (6798 bp) and the New 
Zealand (9309 bp) types.  However, the Asia, 
the Africa, and the Toronto type plasmids 
have been associated with epidemic 
outbreaks while the others have been isolated 
sporadically. Prevalence of each plasmid 
type is varied depending on geographic 
location. Knapp et al (1997b) have reported 
in Manila in 1994 that PPNG accounts for 66 
(93%) of 71 penicillin resistance isolates. 
Among these PPNG, the Asia, the Africa, 
and the Toronto type β-lactamase plasmids 
represent for 18.2%, 68.2%, and 12.1%, 
respectively. In Thailand, the Africa type 
plasmid is on the increasing trend from 3.8% 
during 1994-1995 (Knapp et al., 1997c) to 
24.2% in 2000 (this study) and 69.9% in 
2002 (this study). While the Asia type 
plasmid shows a declining trend from 96.2% 
during 1994-1995 (Knapp et al., 1997c) to 
27.3% in 2000 (this study) and 11.3% in 
2002 (this study). The Toronto type plasmid 
also shows decreasing from 48.5% in 2000 
(this study) to 18.8% in 2002 (this study). In 
addition, all three kinds of epidemiologically 
penicillin resistance plasmids of N. 
gonorrhoeae can be transferred by artificial 
transformation and expressed in E. coli. This 
has also been reported in the cases of 
Haemophilus ducreyi (Prachayasittikul et al., 
2000). Several groups have proposed that 
β−lactamase-producing plasmids of 
gonococci may possibly originate from a H. 
ducreyi host via transformation involving the 
Asia and the Africa progenitor (Roberts, 
1989). 
Our findings also reveal the significant 
increase on the prevalence of multiple 
resistance determinants (penicillin and 
quinolones) coexisting in a single isolate. 
However, quinolone resistance gene can not 
be co-transferred with ampicillin resistance 
plasmid to E. coli. In general, quinolone 
resistance involves chromosomal mutation 
that modifies the target DNA gyrase (or 
DNA topoisomerase IV) or accelerates the 
efflux to decrease quinolone accumulation. 
There are only sporadic reports of plasmid-
mediated quinolone resistance (Piddock, 
1999). However, multiple resistance plasmid 
transferring has been reported in the case of 
Klebsiella pneumoniae to other 
Enterobacteriaceae and Pseudomonas 
aeruginosa (Martinez-Martinez et al., 1998).  
In summary, N. gonorrhoeae strains in 
Thailand belong to a variety of 
penicillin/quinolone resistance phenotypes. A 
significant increase on the prevalence of 
multiple resistance determinants (penicillin 
and quinolones) coexisting in a single isolate 
is also reported. All penicillin resistance 
isolates produce β−lactamase by carrying one 
of the epidemic β−lactamase plasmids of the 
Asia, the Africa, or the Toronto type. 
However, the diversity of genomic 
distribution has been found. The Africa 
plasmid type is the most prevalence and 
being on the increasing trend. Emergence and 
spread of antibiotic resistance may have been 
partially due to the widely use of the drugs 
for the treatment of gonorrhoeae and other 
diseases. Penicillin and quinolones are no 
longer recommended for the treatment of 
gonorrhea in Southeast Asian countries 
although ciprofloxacin is still recommended 
by the World Health Organization (WHO) 
and the Centers for Disease Control and 
Prevention (CDC). These data indicate that 
antimicrobial resistance is an important 
factor when considering the choice of agents 
for the treatment of gonococcal infections. In 
addition, the gonococcal β−lactamase 
producing plasmids can be used as a marker 
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for epidemiologically benefit along with the 
susceptibility pattern. Furthermore, the 
mobility of the episomes infers the high 
tendency of drug resistance development 
among infectious microorganisms in this 
region. The assessment of the antimicrobial 
resistance is of great importance to monitor 
the emergence and spread of resistance and 
planning of appropriate treatment regimens.  
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